SCHEMBL13854495

SCHEMBL13854495

c1ccc(N(c2ccccc2)c2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccc(-c6ccc(N(c7ccccc7)c7ccccc7)cc6)c6ccccc56)cc4)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.45
▸ RXRB P28702 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CRHBP P24387 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.35
▸ APP P05067 3/20 0.34
▸ PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14263615 1.00 RXRA (0.45) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL17690917 0.98 RXRA (0.44) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL10135814 0.98 RXRA (0.44) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL2604807 0.98 RXRA (0.44) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL10136346 0.98 RXRA (0.44) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL24154509 0.98 RXRA (0.44) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL2446726 0.98 RXRA (0.46) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL14263589 0.98 RXRA (0.46) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL29444832 0.98 RXRA (0.46) RXRARXRBALDH1A1L3MBTL1KDM4E
SCHEMBL13903627 0.96 RXRA (0.45) RXRARXRBALDH1A1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090115320-A1 AROMATIC TRIAMINE COMPOUND AND ORGANIC ELECTTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090115320-A1 AROMATIC TRIAMINE COMPOUND AND ORGANIC ELECTTROLUMINESCENCE DEVICE USING THE SAME EML4, ACVRL1, APOL1 RXRA 3551/4885RXRB 4100/4885ALDH1A1 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback